● Recruiting

A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Levels and Participant Satisfaction in Participants With Multiple Sclerosis (MS)

Condition: Multiple Sclerosis · Sponsor: Hoffmann-La Roche

PhaseN/A

Planned participants842

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

The main purpose of the study is to evaluate participant satisfaction after administration of ocrelizumab subcutaneously (SC) after 12 months using the therapy administration satisfaction questionnaire subcutaneous (TASQ-SC).

This description comes directly from the study's public registry record.

Talk to the study team

Reference Study ID Number: ML45551 https://forpatients.roche.com/ No attachments to email below · 888-662-6728 (U.S. Only) · global-roche-genentech-trials@gene.com

Fastest response: use the inquiry form https://www.gene.com/contact-us/submit-medical-inquiry

Always discuss trial participation with your own doctor first.

Locations (92)

Uniklinik RWTH Aachen	Aachen, Germany	Recruiting
Gesundheitszentrum St. Marien GmbH	Amberg, Germany	Recruiting
Sächsisches Krankenhaus Arnsdorf	Arnsdorf, Germany	Recruiting
Neuropraxis im Stadtpalais Dres. Ulzheimer/Herröder/Wessig GbR	Aschaffenburg, Germany	Recruiting
Neurologie Bad Soden	Bad Soden, Germany	Recruiting
Neurologische Praxis - Kallmann Neurologie - mszb	Bamberg, Germany	Recruiting
Marianne-Strauß-klinik	Berg, Germany	Recruiting
Neurologisches Facharztzentrum Berlin am Sankt Gertrauden-Krankenhaus	Berlin, Germany	Recruiting
NEUROZENTRUM tempelhof.berlin	Berlin, Germany	Recruiting
Praxis Dr. Said Masri	Berlin, Germany	Recruiting
Jüdisches Krankenhaus Berlin	Berlin, Germany	Recruiting
NeuroZentrum Zehlendorf Dr. Ringel und Dr. Scherer	Berlin, Germany	Recruiting

+ 80 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06780150